Literature DB >> 26718277

Cancer: Engineered T cells gain access to pancreatic tumours.

Alexandra Flemming.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26718277     DOI： 10.1038/nrd.2015.40

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma.

Authors:  Philip D Greenberg; Sunil R Hingorani; Ingunn M Stromnes; Thomas M Schmitt; Ayaka Hulbert; J Scott Brockenbrough; Hieu Nguyen; Carlos Cuevas; Ashley M Dotson; Xiaoxia Tan; Jennifer L Hotes
Journal:  Cancer Cell       Date:  2015-10-29       Impact factor: 31.743
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.